Pharmaceutical Statistics

Papers
(The H4-Index of Pharmaceutical Statistics is 12. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Generalizing Treatment Effect to a Target Population Without Individual Patient Data in a Real‐World Setting39
Prediction Intervals for Overdispersed Binomial Endpoints and Their Application to Toxicological Historical Control Data29
A Likelihood Perspective on Dose‐Finding Study Designs in Oncology22
Average Hazard as Harmonic Mean19
Using an early outcome as the sole source of information of interim decisions regarding treatment effect on a long‐term endpoint: The non‐Gaussian case19
Using Off‐Treatment Sequential Multiple Imputation for Binary Outcomes to Address Intercurrent Events Handled by a Treatment Policy Strategy18
Prospectively Specified Adaptive Bayesian Borrowing: Considerations, Methodologies, and Implementations17
Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information Sources16
Frailty model with change points for survival analysis14
A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non‐Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial Design14
Pre‐Posterior Distributions in Drug Development and Their Properties13
Improved inference forMCP‐Modapproach using time‐to‐event endpoints with small sample sizes13
To Dilute or Not to Dilute: Nominal Titer Dosing for Genetic Medicines12
A conservative approach to leveraging external evidence for effective clinical trial design12
Issue Information12
Control of Unconditional Type I Error in Clinical Trials With External Control Borrowing—A Two‐Stage Adaptive Design Perspective12
A Bayesian method for safety signal detection in ongoing blinded randomised controlled trials12
Improving early phase oncology clinical trial design: The case for finding the optimal biological dose12
0.86233496665955